Alerts will be sent to your verified email
Verify Email
INNOVACAP
|
Innova Captab
|
Senores Pharmaceutic
|
Suven Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.73 % | 11.02 % | -82.05 % |
|
5yr average Equity Multiplier
|
2.34 | 2.25 | 1.55 |
|
5yr Average Asset Turnover Ratio
|
1.03 | 0.3 | 0.05 |
|
5yr Avg Net Profit Margin
|
8.55 % | 15.05 % | -1150.51 % |
|
Price to Book
|
3.8 | 4.44 | 12.45 |
|
P/E
|
29.29 | 35.59 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
31.3 Days | -30.87 Days | 97.84 Days |
|
Inventory Days
|
52.34 Days | 46.48 Days | 10.88 Days |
|
Days Receivable
|
89.43 Days | 108.09 Days | 71.91 Days |
|
Days Payable
|
105.42 Days | 255.02 Days | 3.38 Days |
|
5yr Average Interest Coverage Ratio
|
22.73 | 4.44 | -373.47 |
|
5yr Avg ROCE
|
21.99 % | 10.25 % | -82.34 % |
|
5yr Avg Operating Profit Margin
|
13.36 % | 22.88 % | -1227.3 % |
|
5 yr average Debt to Equity
|
0.55 | 0.83 | 0.0 |
|
5yr CAGR Net Profit
|
30.09 % | 126.15 % | 17.38 % |
|
5yr Average Return on Assets
|
8.63 % | 4.54 % | -54.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.9 % | 45.8 % | 67.36 % |
|
Share Pledged by Promoters
|
0.0 | 1.9 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.04 % | -2.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.18 % | -0.74 % | 2.07 % |
|
Innova Captab
|
Senores Pharmaceutic
|
Suven Life Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|